S Zweizig1, L D Roman, L I Muderspach
1Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles 90033.
A patient experienced fatal anaphylaxis despite precautions when treated with cisplatin for ovarian cancer recurrence. This highlights the severe risks of hypersensitivity reactions to platinum-based chemotherapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: